Novel inhibitors of 3-phosphoglycerate kinase.
Hickey
M J
MJ
Department of Chemistry & Physics, Nottingham Trent University, Clifton, U.K.
Coutts
I G
IG
Tsang-Tan
L L
LL
Pogson
C I
CI
D001567:Benzocycloheptenes / Q000494:pharmacology; D004610:Ellagic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D005419:Flavonoids / Q000494:pharmacology; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D010100:Oxygen / Q000097:blood; D010735:Phosphoglycerate Kinase / Q000037:antagonists & inhibitors*
D001567:Benzocycloheptenes; D004791:Enzyme Inhibitors; D005419:Flavonoids; D006454:Hemoglobins; D004610:Ellagic Acid; C022139:flavellagic acid; C040015:myricetin; D010735:Phosphoglycerate Kinase; C026133:purpurogallin; D010100:Oxygen